SOCIETE EUROPEENNE DE CARDIOLOGIE

Their core work

The European Society of Cardiology (ESC) is the world's largest medical society dedicated to cardiovascular medicine, headquartered in Sophia Antipolis, France. In H2020 projects, ESC contributes its vast clinical registry infrastructure, guideline expertise, and access to a pan-European network of cardiologists and clinical centers. Their role spans coordinating multi-country clinical trials, providing standardized cardiovascular data for research, and translating findings into clinical practice guidelines. They are a critical bridge between cardiovascular research and real-world clinical implementation across Europe.

What they specialise in

How they've shifted over time

In the early H2020 period (2015–2018), ESC focused on understanding cardiovascular disease mechanisms — atrial fibrillation pathophysiology, cardiac hypertrophy, sudden cardiac arrest genetics, and traditional clinical trials (CATCH ME, BETA3_LVH, ESCAPE-NET). From 2019 onward, their work shifted decisively toward digital screening, population-level risk stratification, personalized prevention, and cross-disease research linking cardiovascular conditions with cancer and metabolic disorders (AFFECT-EU, CoroPrevention, TO_AITION, CARDIOCARE). The later period also shows ESC stepping into coordination roles and regulatory science, suggesting a move from pure research participation toward shaping how cardiovascular evidence is generated and applied.

ESC is moving from disease-mechanism research toward population-scale digital screening, personalized prevention strategies, and cardio-oncology — expect future projects at the intersection of cardiovascular medicine, digital health, and multimorbidity.

How they like to work

ESC overwhelmingly participates as a partner (12 of 15 projects), contributing clinical network access and registry infrastructure rather than leading the science. They coordinated only two projects (EHRA-PATHS and CORE-MD), both in areas where their institutional authority — clinical guidelines and regulatory standards — made them natural leaders. With 231 unique consortium partners across 27 countries, they function as a hub organization, connecting diverse clinical centers, universities, and industry partners across Europe.

ESC has collaborated with 231 unique partners across 27 countries, making it one of the most broadly connected organizations in cardiovascular H2020 research. Their network spans virtually all EU member states, reflecting their role as a pan-European professional society with members in every European country.

What sets them apart

ESC is not a university or research institute — it is the professional society representing 100,000+ cardiologists across Europe. This gives it unmatched convening power: access to clinical sites, patient registries, and practicing physicians that no single institution can replicate. For consortium builders, ESC brings instant credibility with clinical reviewers, a ready-made dissemination channel to the cardiology community, and the authority to translate project findings into clinical practice guidelines.

Highlights from their portfolio

• BigData Heart
  Largest EC contribution to ESC (EUR 617K), combining big data analytics with heart failure, AF, and acute coronary syndrome — a flagship cardiovascular data project.
• EHRA-PATHS
  One of only two projects ESC coordinated, addressing the complex intersection of atrial fibrillation with multimorbidity and polypharmacy in elderly patients.
• CORE-MD
  ESC-coordinated project on medical device regulatory science — unusual for a clinical society, signaling ambition to shape evidence standards beyond traditional research.